ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $614 | -89.7% | 386 | -59.7% | 0.00% | -100.0% |
Q4 2022 | $5,975 | -40.2% | 959 | -36.6% | 0.00% | 0.0% |
Q3 2022 | $10,000 | +150.0% | 1,513 | +126.2% | 0.00% | 0.0% |
Q2 2022 | $4,000 | +300.0% | 669 | +457.5% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 120 | +12.1% | 0.00% | – |
Q4 2021 | $1,000 | – | 107 | +409.5% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 21 | -94.4% | 0.00% | -100.0% |
Q2 2016 | $3,000 | – | 377 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |